ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
Fusion Science and Technology
August 2025
Latest News
Powering the future: How the DOE is fueling nuclear fuel cycle research and development
As global interest in nuclear energy surges, the United States must remain at the forefront of research and development to ensure national energy security, advance nuclear technologies, and promote international cooperation on safety and nonproliferation. A crucial step in achieving this is analyzing how funding and resources are allocated to better understand how to direct future research and development. The Department of Energy has spearheaded this effort by funding hundreds of research projects across the country through the Nuclear Energy University Program (NEUP). This initiative has empowered dozens of universities to collaborate toward a nuclear-friendly future.
F. M. Wagner, L. Koester, Th. Auberger, W. Reuschel, M. Mayr, P. Kneschaurek, A. Breit, H. Schraube
Nuclear Science and Engineering | Volume 110 | Number 1 | January 1992 | Pages 32-37
Technical Paper | doi.org/10.13182/NSE92-A23873
Articles are hosted by Taylor and Francis Online.
The fast neutron facility at the Munich Research Reactor [Forschungsreaktor München (FRM)] is briefly described, and data about the beam quality are given. After a listing of the biological experiments performed before and in parallel to the clinical irradiations, the treatment scheme, selection of cases and results of the reactor neutron therapy are reported. More than 80% of patients— all with poor prognosis — show complete remission of the tumor or stoppage of growth for at least several months. Possibilities for a support by boron neutron capture therapy are outlined. Preliminary data of an upgraded thermal-to-fast neutron converter for the planned 20-MW reactor FRM-II are given.
